General Information


DRACP ID  DRACP03669

Peptide Name  

Sequence  PKX

Sequence Length  3

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Picolinoyl

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C11H19N3O2

Absent amino acids  ACDEFGHILMNQRSTVWY

Common amino acids  KPX

Mass  37114

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  0

Net charge  1

Boman Index  -555

Hydrophobicity  -183.33

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25759383

Title  Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  10799

DRACP is developed by Dr.Zheng's team.